IN2014MN02214A - - Google Patents
Info
- Publication number
- IN2014MN02214A IN2014MN02214A IN2214MUN2014A IN2014MN02214A IN 2014MN02214 A IN2014MN02214 A IN 2014MN02214A IN 2214MUN2014 A IN2214MUN2014 A IN 2214MUN2014A IN 2014MN02214 A IN2014MN02214 A IN 2014MN02214A
- Authority
- IN
- India
- Prior art keywords
- formulations
- incision
- infiltration
- administered
- injection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261645066P | 2012-05-10 | 2012-05-10 | |
| US201261649400P | 2012-05-21 | 2012-05-21 | |
| US201361781625P | 2013-03-14 | 2013-03-14 | |
| US201361781595P | 2013-03-14 | 2013-03-14 | |
| PCT/IL2013/050410 WO2013168172A1 (en) | 2012-05-10 | 2013-05-09 | Depot formulations of a local anesthetic and methods for preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02214A true IN2014MN02214A (en:Method) | 2015-07-17 |
Family
ID=49550270
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2214MUN2014 IN2014MN02214A (en:Method) | 2012-05-10 | 2013-05-09 | |
| IN2213MUN2014 IN2014MN02213A (en:Method) | 2012-05-10 | 2013-05-09 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2213MUN2014 IN2014MN02213A (en:Method) | 2012-05-10 | 2013-05-09 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US9668974B2 (en:Method) |
| EP (2) | EP2846772A4 (en:Method) |
| JP (4) | JP2015516412A (en:Method) |
| CN (2) | CN104427976B (en:Method) |
| AU (2) | AU2013257546B2 (en:Method) |
| CA (2) | CA2871820C (en:Method) |
| IN (2) | IN2014MN02214A (en:Method) |
| RU (2) | RU2664700C2 (en:Method) |
| WO (2) | WO2013168167A1 (en:Method) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2014MN02214A (en:Method) * | 2012-05-10 | 2015-07-17 | Painreform Ltd | |
| GB201505527D0 (en) | 2015-03-31 | 2015-05-13 | Jmedtech Pte Ltd | Composition |
| FI3331516T3 (fi) * | 2015-07-13 | 2024-11-18 | Neon Laboratories Ltd | Ropivakaiinihydrokloridin hyperbaarinen liuosinjektio ja menetelmä sen valmistamiseksi |
| WO2019071246A2 (en) | 2017-10-06 | 2019-04-11 | Foundry Therapeutics, Inc. | IMPLANTABLE DEPOSITS FOR CONTROLLED RELEASE OF ANALGESICS TO TREAT POSTOPERATIVE PAIN, AND DEVICES, SYSTEMS, AND RELATED METHODS |
| US10716774B1 (en) | 2018-01-05 | 2020-07-21 | Yale Pharmaceuticals LLC | Pharmaceutical compositions containing isotretinoin with improved dissolution profile and enhanced stability |
| WO2019136490A1 (en) | 2018-01-08 | 2019-07-11 | Foundry Therapeutics, Inc. | Devices, systems, and methods for treating intraluminal cancer via controlled delivery of therapeutic agents |
| US12458589B2 (en) | 2018-05-12 | 2025-11-04 | Foundry Therapeutics, Inc. | Implantable polymer depots for the controlled release of therapeutic agents |
| WO2019226599A1 (en) * | 2018-05-22 | 2019-11-28 | Alkalidx, Inc. | Diagnostics and treatments of anesthetic insensitive subjects |
| EP3843710A1 (en) | 2018-08-28 | 2021-07-07 | Foundry Therapeutics, Inc. | Polymer implants |
| CN109316602A (zh) * | 2018-11-13 | 2019-02-12 | 西安力邦医药科技有限责任公司 | 一种长效镇痛并促进伤口愈合的复方缓释递药系统的组方与应用 |
| JP7378929B2 (ja) * | 2018-12-27 | 2023-11-14 | 花王株式会社 | リポソームの製造方法 |
| CN111388418B (zh) * | 2018-12-31 | 2022-09-06 | 北京泰德制药股份有限公司 | 一种含有罗哌卡因或其药用盐的药物组合物 |
| US20220249375A1 (en) * | 2019-06-28 | 2022-08-11 | Jiangsu Hengrui Medicine Co., Ltd. | Sustained-release lipid composition and preparation method therefor |
| WO2021143745A1 (zh) * | 2020-01-14 | 2021-07-22 | 中国科学院上海药物研究所 | 一种长效罗哌卡因药物组合物及其制备方法和用途 |
| CN118304253A (zh) * | 2021-01-14 | 2024-07-09 | 南京清普生物科技有限公司 | 一种缓释制剂组合物 |
| US11992483B2 (en) | 2021-03-31 | 2024-05-28 | Cali Biosciences Us, Llc | Emulsions for local anesthetics |
| CN115463084B (zh) * | 2021-06-10 | 2024-05-28 | 北京泰德制药股份有限公司 | 一种长效镇痛用复方油溶液制剂及其制备方法 |
| US12396937B2 (en) | 2021-09-15 | 2025-08-26 | Ocusoft, Inc. | Ointments for treating dry skin |
| US20240065995A1 (en) * | 2022-08-27 | 2024-02-29 | Darren Alexander Rubin | Injectable methods to treat deficiencies in glutathione metabolism and homocystinuria |
Family Cites Families (114)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4252793A (en) | 1979-06-18 | 1981-02-24 | American Lecithin Company | Injectable lecithin preparation |
| JPH0753661B2 (ja) | 1984-03-08 | 1995-06-07 | フアレス フアーマスーチカル リサーチ エヌブイ | プロ―リポソーム組成物及びリポソームの水性分散物を作る方法 |
| US5173219A (en) | 1986-02-12 | 1992-12-22 | Research Development Foundation | Uniform spherical multilamellar liposomes of defined and adjustable size distribution |
| US5723147A (en) | 1987-02-23 | 1998-03-03 | Depotech Corporation | Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride |
| NZ223660A (en) | 1987-03-05 | 1990-11-27 | Liposome Co Inc | Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity |
| CH681427A5 (en:Method) | 1987-07-01 | 1993-03-31 | Zambon Spa | |
| US5807572A (en) | 1988-02-18 | 1998-09-15 | Depotech Corporation | Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride |
| US5422120A (en) | 1988-05-30 | 1995-06-06 | Depotech Corporation | Heterovesicular liposomes |
| US5576017A (en) | 1988-05-30 | 1996-11-19 | Depotech Corporation | Heterovesicular liposomes |
| US5538739A (en) | 1989-07-07 | 1996-07-23 | Sandoz Ltd. | Sustained release formulations of water soluble peptides |
| MY107937A (en) | 1990-02-13 | 1996-06-29 | Takeda Chemical Industries Ltd | Prolonged release microcapsules. |
| CA2120359C (en) * | 1991-10-04 | 2000-12-26 | Tomas Landh | Particles, method of preparing said particles and uses thereof |
| SE9200952D0 (sv) * | 1992-03-27 | 1992-03-27 | Kabi Pharmacia Ab | Pharmaceutical carrier system containing defined lipids |
| US5922340A (en) | 1992-09-10 | 1999-07-13 | Children's Medical Center Corporation | High load formulations and methods for providing prolonged local anesthesia |
| SI9300468A (en) | 1992-10-14 | 1994-06-30 | Hoffmann La Roche | Injectable composition for the sustained release of biologically active compounds |
| WO1994012158A1 (en) | 1992-12-02 | 1994-06-09 | Alkermes Controlled Therapeutics, Inc. | Controlled release growth hormone containing microspheres |
| ES2188612T3 (es) | 1993-04-22 | 2003-07-01 | Skyepharma Inc | Liposomas multivesiculares de ciclodextrina para encapsular compuestos farmacologicos y metodos para su uso. |
| US5455044A (en) | 1993-05-14 | 1995-10-03 | Depotech Corporation | Method for treating neurological disorders |
| SE9302218D0 (sv) * | 1993-06-28 | 1993-06-28 | Ab Astra | New use |
| PT707472E (pt) * | 1993-07-08 | 2001-07-31 | Liposome Co Inc | Processo para controlar a dimensao de lipossomas |
| HUT75162A (en) | 1993-11-16 | 1997-04-28 | Depotech Corp | Vesicles with controlled release of actives |
| US5766627A (en) | 1993-11-16 | 1998-06-16 | Depotech | Multivescular liposomes with controlled release of encapsulated biologically active substances |
| SI0729357T1 (en) | 1993-11-19 | 2005-06-30 | Janssen Pharmaceutica N.V. | Microencapsulated 1,2-benzazoles |
| US5635206A (en) | 1994-01-20 | 1997-06-03 | Hoffmann-La Roche Inc. | Process for liposomes or proliposomes |
| US5693337A (en) | 1994-07-13 | 1997-12-02 | Wakamoto Pharmaceutical Co., Ltd. | Stable lipid emulsion |
| US5993850A (en) | 1994-09-13 | 1999-11-30 | Skyepharma Inc. | Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances |
| HU223475B1 (hu) * | 1994-10-24 | 2004-07-28 | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. | Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására |
| US5660854A (en) | 1994-11-28 | 1997-08-26 | Haynes; Duncan H | Drug releasing surgical implant or dressing material |
| US6160018A (en) | 1995-03-13 | 2000-12-12 | Loma Linda University Medical Center | Prophylactic composition and method for alzheimer's Disease |
| US5955504A (en) | 1995-03-13 | 1999-09-21 | Loma Linda University Medical Center | Colorectal chemoprotective composition and method of preventing colorectal cancer |
| US5981592A (en) | 1995-03-13 | 1999-11-09 | Loma Linda University Medical Center | Method and composition for treating cystic fibrosis |
| US5931809A (en) | 1995-07-14 | 1999-08-03 | Depotech Corporation | Epidural administration of therapeutic compounds with sustained rate of release |
| US6008256A (en) | 1995-08-28 | 1999-12-28 | Showa Yakuhin Kako Co., Ltd. | Composition for local anesthesia |
| ATE183092T1 (de) | 1995-10-28 | 1999-08-15 | Braun Melsungen Ag | Lokalanästhetika und/oder zentralanalgetika enthaltende pharmazeutische zusammensetzungen |
| US5744337A (en) * | 1995-12-26 | 1998-04-28 | The United States Of America As Represented By The Secretary Of The Navy | Internal gelation method for forming multilayer microspheres and product thereof |
| FR2753626B1 (fr) | 1996-09-20 | 1998-11-06 | Centre International De Rech Dermatologiques Galderma Cird Galderma | Nouvelles compositions topiques sous forme d'emulsion fluide h/e a forte teneur en glycol pro-penetrant |
| US5997899A (en) | 1996-10-01 | 1999-12-07 | Skyepharma Inc. | Method for producing liposomes with increased percent of compound encapsulated |
| US5891467A (en) | 1997-01-31 | 1999-04-06 | Depotech Corporation | Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes |
| US6326020B1 (en) * | 1997-05-16 | 2001-12-04 | Children's Medical Center Corporation | Local anesthetic formulations |
| GB2326337A (en) | 1997-06-20 | 1998-12-23 | Phares Pharma Holland | Homogeneous lipid compositions for drug delivery |
| US6306432B1 (en) | 1997-09-08 | 2001-10-23 | Chiron Corporation | High and low load formulations of IGF-I in multivesicular liposomes |
| US6106858A (en) | 1997-09-08 | 2000-08-22 | Skyepharma, Inc. | Modulation of drug loading in multivescular liposomes |
| EP2198854B1 (en) | 1997-09-18 | 2011-11-30 | Pacira Pharmaceuticals, Inc. | Sustained-release liposomal anesthetic compositions |
| SE512663C2 (sv) | 1997-10-23 | 2000-04-17 | Biogram Ab | Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer |
| DE69828615T2 (de) | 1997-10-31 | 2005-12-01 | Walter Reed Army Institute Of Research | Verwendung von inhibitoren der komplementaktivierung zur herstellung eines medikaments zur inhibierung von nebenwirkungen von pharmazeutischen zusammensetzungen, die amphiphile träger oder wirkstoffträger moleküle enthalten |
| WO1999025319A1 (en) | 1997-11-14 | 1999-05-27 | Depotech Corporation | Production of multivesicular liposomes |
| BE1011899A6 (fr) | 1998-04-30 | 2000-02-01 | Ucb Sa | Compositions pharmaceutiques gelifiables utilisables. |
| WO2000003660A1 (en) | 1998-07-17 | 2000-01-27 | Skyepharma, Inc. | Biodegradable compositions for the controlled release of encapsulated substances |
| RU2178293C2 (ru) * | 1998-08-18 | 2002-01-20 | Панацея Биотек Лимитед | Фармацевтическая композиция, содержащая циклоспорин, способ получения мягких желатиновых капсул |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| GB9907715D0 (en) * | 1999-04-01 | 1999-05-26 | Scherer Corp R P | Pharmaceutical compositions |
| CA2375371A1 (en) | 1999-06-04 | 2000-12-14 | Skyepharma Inc. | Oil-core compositions for the sustained release of hydrophobic drugs |
| KR100343125B1 (ko) | 1999-09-14 | 2002-07-05 | 임정옥 | 도포용 리포좀형 혼합국소마취제 및 그 제조방법 |
| EP1138313A1 (de) * | 2000-03-28 | 2001-10-04 | Primacare S.A. | Pro-liposomen |
| US6761901B1 (en) | 2000-05-02 | 2004-07-13 | Enzrel Inc. | Liposome drug delivery |
| IL139177A0 (en) | 2000-10-20 | 2001-11-25 | S C Republic Dev S R L | Sustained release drug delivery system |
| JP2004532252A (ja) | 2001-05-31 | 2004-10-21 | スカイファーマ インコーポレーテッド | リポソームおよびミクロスフェア中のナノ懸濁物のカプセル化 |
| US20030099674A1 (en) | 2001-08-11 | 2003-05-29 | Chen Andrew X. | Lyophilized injectable formulations containing paclitaxel or other taxoid drugs |
| KR20050044655A (ko) | 2001-12-03 | 2005-05-12 | 노바세아, 인크. | 활성 비타민 ｄ 화합물을 함유하는 약제학적 조성물 |
| JP2005528390A (ja) | 2002-04-10 | 2005-09-22 | コンフォーマ・セラピューティクス・コーポレイション | アンサマイシン製剤およびその製造ならびに使用方法 |
| US20030236306A1 (en) | 2002-06-20 | 2003-12-25 | Chen Andrew X. | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof |
| US7229630B2 (en) | 2002-06-20 | 2007-06-12 | Novalar Pharmaceuticals, Inc. | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof |
| WO2004024225A1 (en) * | 2002-09-16 | 2004-03-25 | Zicam, Llc. | System and method for delivering a composition to the nasal membrane |
| JP2006510603A (ja) | 2002-10-07 | 2006-03-30 | アンコール ファーマスーティカルズ インコーポレイテッド | Ｒ−非ステロイド性抗炎症薬エステル及びそれらの使用 |
| US20050026877A1 (en) | 2002-12-03 | 2005-02-03 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
| US20060189586A1 (en) | 2003-06-11 | 2006-08-24 | Cleland Jeffrey L | Pharmaceutical compositions comprising active vitamin D compounds |
| US20050020546A1 (en) | 2003-06-11 | 2005-01-27 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
| US20050049209A1 (en) | 2003-08-06 | 2005-03-03 | Chen Andrew Xian | Pharmaceutical compositions for delivering macrolides |
| US20050118206A1 (en) | 2003-11-14 | 2005-06-02 | Luk Andrew S. | Surfactant-based gel as an injectable, sustained drug delivery vehicle |
| US7968122B2 (en) | 2003-12-10 | 2011-06-28 | Adventrx Pharmaceuticals, Inc. | Anti-viral pharmaceutical compositions |
| US20050186230A1 (en) | 2004-01-23 | 2005-08-25 | Sd Pharmaceuticals, Inc. | Elemene compositions containing liquid oil |
| EP1729784A1 (en) | 2004-02-23 | 2006-12-13 | Attenuon, LLC | Formulations of thiomolybdate or thiotungstate compounds and uses thereof |
| ES2309766T3 (es) * | 2004-06-04 | 2008-12-16 | Camurus Ab | Formulaciones liquidas de liberacion lenta. |
| CN101027065A (zh) * | 2004-06-15 | 2007-08-29 | 陈献 | 磷脂组合物及其制备和使用方法 |
| US7871632B2 (en) | 2004-07-12 | 2011-01-18 | Adventrx Pharmaceuticals, Inc. | Compositions for delivering highly water soluble drugs |
| CA2575216A1 (en) | 2004-07-28 | 2006-02-09 | Sd Pharmaceuticals, Inc. | Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof |
| US8557861B2 (en) | 2004-09-28 | 2013-10-15 | Mast Therapeutics, Inc. | Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
| BRPI0612802A2 (pt) | 2005-07-07 | 2010-11-30 | Farnam Co Inc | composições farmacêuticas de liberação sustentada para medicamentos extremamente hidrossolúveis |
| US20070078434A1 (en) * | 2005-09-30 | 2007-04-05 | Vyteris, Inc. | Indications For Local Transport of Anaesthetic Agents By Electrotransport Devices |
| AU2006320388A1 (en) | 2005-12-02 | 2007-06-07 | Adventrx Pharmaceuticals, Inc. | Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate |
| CN100486569C (zh) * | 2006-01-06 | 2009-05-13 | 中国药科大学 | 一种多烯紫杉醇自组装前体脂质体及其制备方法 |
| CN100563715C (zh) * | 2006-01-06 | 2009-12-02 | 中国药科大学 | 一种紫杉醇自组装前体脂质体及其制备方法 |
| CN100518738C (zh) * | 2006-01-06 | 2009-07-29 | 中国药科大学 | 一种含喜树碱类药物的自组装前体脂质体及其制备方法 |
| TWI376239B (en) | 2006-02-01 | 2012-11-11 | Andrew Xian Chen | Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| JP2010512341A (ja) * | 2006-12-07 | 2010-04-22 | リオトロピック セラピュティックス アイエヌシー． | 麻酔薬および他の化合物の逆転および解毒用組成物ならびにその使用方法 |
| EP1938801A1 (en) | 2006-12-22 | 2008-07-02 | Biofrontera Bioscience GmbH | Nanoemulsion |
| US20100041704A1 (en) * | 2007-01-12 | 2010-02-18 | Aberg A K Gunnar | Dermal compositions of substituted amides and the use thereof as medication for pain and pruritus |
| JP5452236B2 (ja) | 2007-03-02 | 2014-03-26 | ファーナム・カンパニーズ・インコーポレーテッド | ロウ様物質を用いた徐放性組成物 |
| EP2146692A1 (en) * | 2007-03-19 | 2010-01-27 | Fresenius Kabi Oncology Limited | Proliposomal and liposomal compositions |
| BRPI0704542B8 (pt) | 2007-05-15 | 2021-05-25 | Univ Estadual Campinas Unicamp | composição farmacêutica, processo de obtenção da composição farmacêutica, uso de uma quantidade farmaceuticamente eficaz de anestésico e agente gelificante, produto e método de tratamento |
| RU2429242C2 (ru) * | 2007-05-30 | 2011-09-20 | Учреждение Российской Академии Наук Институт Проблем Химической Физики Ран (Ипхф Ран) | Применение тетранитрозильного комплекса железа с тиофенолом в качестве противоопухолевого лекарственного средства |
| HUP0700426A2 (en) | 2007-06-19 | 2010-03-29 | Invencio 21 Gyogyhatasu Keszit | Liposomal compound |
| US20100310661A1 (en) | 2007-07-16 | 2010-12-09 | Poniard Pharmaceuticals, Inc. | Oral formulations for picoplatin |
| FR2924024B1 (fr) | 2007-11-27 | 2012-08-17 | Centre Nat Rech Scient | Nanoparticules d'actifs therapeutiques de faible solubilite aqueuse |
| CN101485629B (zh) | 2008-01-16 | 2013-01-23 | 沈阳药科大学 | 一种给药系统及其制备方法 |
| JP5608653B2 (ja) | 2008-09-04 | 2014-10-15 | ファーナム・カンパニーズ・インコーポレーテッド | チュアブルな徐放性製剤 |
| CN102202672A (zh) | 2008-10-10 | 2011-09-28 | 达拉生物科学公司 | 使用穗霉素衍生物治疗或预防疼痛的方法 |
| US20100305500A1 (en) | 2009-05-29 | 2010-12-02 | Pacira Pharmaceuticals, Inc. | Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent |
| WO2011025771A1 (en) | 2009-08-25 | 2011-03-03 | Biogen Idec Ma Inc. | Compositions for delivery of insoluble agents |
| WO2011075623A1 (en) | 2009-12-18 | 2011-06-23 | Latitude Pharmaceuticals, Inc. | One - phase gel compos ition compri s ing phos pholi pids |
| EP2336286A1 (en) * | 2009-12-18 | 2011-06-22 | The Procter & Gamble Company | Composition comprising microcapsules |
| WO2011096953A1 (en) | 2010-02-05 | 2011-08-11 | Cenerx Biopharma, Inc. | Oral antidepressant formulation with reduced excipient load |
| US20140066481A1 (en) | 2010-04-01 | 2014-03-06 | Pharmanest Ab | Water-Free Pharmaceutical Compositions Suitable for Local Anaesthetics |
| JP6043278B2 (ja) | 2010-04-09 | 2016-12-14 | パシラ ファーマシューティカルズ インコーポレーテッド | 多小胞リポソームを作製するための方法、大直径合成膜小胞を調製するための方法、および蒸発装置 |
| US9770414B2 (en) | 2010-05-13 | 2017-09-26 | Pacira Pharmaceuticals, Inc. | Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent |
| CN102939077B (zh) | 2010-06-03 | 2016-04-06 | 莱迪杜德制药公司 | 含有维生素k的纳米乳液组合物 |
| EP2588081A4 (en) | 2010-06-29 | 2014-12-10 | Verastem Inc | ORAL FORMULATION OF CHINESE INHIBITORS |
| EP2593089B1 (en) | 2010-07-14 | 2018-04-04 | Senju Pharmaceutical Co., Ltd. | Solid dispersion of alfa-ketoamide derivative |
| NZ608210A (en) | 2010-08-20 | 2015-02-27 | Reddy’S Lab Ltd Dr | Phospholipid depot |
| WO2012037311A1 (en) * | 2010-09-17 | 2012-03-22 | Maine Natural Health, Inc. | Compositions containing omega-3 oil and uses thereof |
| PT2629779T (pt) | 2010-10-22 | 2017-09-22 | Dr Reddy's Laboratories Sa | Utilização de depósito de fosfolípidos viscosos estáveis em armazenamento para tratar feridas |
| US10610486B2 (en) | 2010-10-28 | 2020-04-07 | Pacira Pharmaceuticals, Inc. | Sustained release formulation of a non-steroidal anti-inflammatory drug |
| WO2012170796A1 (en) | 2011-06-09 | 2012-12-13 | Amylin Pharmaceuticals, Inc. | Gel compositions |
| IN2014MN02214A (en:Method) * | 2012-05-10 | 2015-07-17 | Painreform Ltd |
-
2013
- 2013-05-09 IN IN2214MUN2014 patent/IN2014MN02214A/en unknown
- 2013-05-09 CN CN201380036669.XA patent/CN104427976B/zh active Active
- 2013-05-09 AU AU2013257546A patent/AU2013257546B2/en active Active
- 2013-05-09 RU RU2014144500A patent/RU2664700C2/ru active
- 2013-05-09 CA CA2871820A patent/CA2871820C/en active Active
- 2013-05-09 JP JP2015510944A patent/JP2015516412A/ja active Pending
- 2013-05-09 WO PCT/IL2013/050404 patent/WO2013168167A1/en not_active Ceased
- 2013-05-09 RU RU2014144501A patent/RU2678433C2/ru active
- 2013-05-09 IN IN2213MUN2014 patent/IN2014MN02213A/en unknown
- 2013-05-09 CN CN201380036700.XA patent/CN104427977B/zh active Active
- 2013-05-09 JP JP2015510942A patent/JP2015516411A/ja active Pending
- 2013-05-09 US US14/399,815 patent/US9668974B2/en active Active
- 2013-05-09 CA CA2871821A patent/CA2871821C/en active Active
- 2013-05-09 AU AU2013257608A patent/AU2013257608B2/en active Active
- 2013-05-09 EP EP13787409.5A patent/EP2846772A4/en active Pending
- 2013-05-09 US US14/399,884 patent/US9849088B2/en active Active
- 2013-05-09 EP EP13787930.0A patent/EP2846773A4/en active Pending
- 2013-05-09 WO PCT/IL2013/050410 patent/WO2013168172A1/en not_active Ceased
-
2017
- 2017-05-02 US US15/584,391 patent/US10206876B2/en active Active
- 2017-10-03 JP JP2017193516A patent/JP6574228B2/ja active Active
- 2017-10-04 JP JP2017194260A patent/JP6577548B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN02214A (en:Method) | ||
| MX2021001231A (es) | Compuestos heterociclicos y sus usos. | |
| IN2014DN10670A (en:Method) | ||
| MX2020002693A (es) | Formulaciones farmaceuticas estabilizadas de analogos de insulina y/o derivados de insulina. | |
| CL2014003232A1 (es) | Formulaciones y métodos para la administración vaginal de antiprogestinas. | |
| EP2702994A3 (en) | Methods of administering pirfenidone therapy | |
| SG10201804817TA (en) | Delayed release compositions of linaclotide | |
| EP2803340A4 (en) | SYSTEM FOR PLACING MULTI-BRANCH ENDOPROSTHETICS AND CATHETER-GUIDE THEREFOR | |
| MX2015012416A (es) | Compuestos heterociclicos y sus usos. | |
| MX2016005395A (es) | Formulacion estable de insulina glulisina. | |
| IN2014MN02236A (en:Method) | ||
| WO2014160281A3 (en) | Method of enhancing delivery of therapeutic compounds to the eye | |
| PL2922576T3 (pl) | Sposoby podawania i oceny leków wychwytujących azot do leczenia encefalopati wątrobowej | |
| EP2981258B8 (en) | Pharmaceutical formulations for subcutaneous administration of furosemide | |
| EP3162804A8 (en) | New benzodiazepine derivative and use thereof | |
| EP2898912A4 (en) | Drug administration instrument | |
| PH12016501117A1 (en) | Pharmaceutical compositions of carotenoid | |
| IL236562A0 (en) | A pharmaceutical preparation with an improved flow capacity, a medical agent, and a method for its production and use | |
| EP2668952A3 (en) | Aqueous formulations of bisphosphonates, vitamin D and benzyl alcohol suitable for subcutaneous or intramuscular use | |
| EA201491477A1 (ru) | Фармацевтические составы, содержащие флупиртин | |
| ZA201303220B (en) | Stable pharmaceutical composition of a benzimidazole proton pump inhibitor and method for the preparation thereof | |
| UA73592U (ru) | Применение экстракта травы герани крупнокорневищной как средства с противовоспалительной и обезболивающей активностью | |
| UA65038U (ru) | Способ лечения больных послеродовыми психозами | |
| MX2013003022A (es) | Composiciones farmaceuticas de montelukast y levocetirizina. | |
| EP3060179A4 (en) | Vaginal inserted estradiol pharmaceutical compositons and methods |